ROR2 调节胰腺瘤和腺癌中的细胞可塑性
Simone Benitz1, Alec Steep2, Malak M Nasser1
1Department of Surgery, Henry Ford Health, Detroit, Michigan.
Cancer discovery
|July 8, 2024
概括
胰腺癌中的细胞可塑性涉及到细胞身份的变化. 受体氨酸激酶ROR2驱动了侵袭性胰腺管腺癌 (PDAC) 和对KRAS抑制剂的耐药性.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 细胞可塑性对于胰腺管腺癌 (PDAC) 的发展和进展至关重要.
- 正常的状细胞分化,由PDX1调节,通常会抑制胃细胞的身份.
研究的目的:
- 研究细胞身份在PDAC中的作用.
- 在PDAC中识别细胞可塑性的调节剂和治疗点.
主要方法:
- 对小鼠和人类胰腺癌样本的分析.
- 在小鼠模型中进行基因操纵 (Ror2的切除).
- 研究受体氨酸激酶ROR2的功能.
主要成果:
- 在PDAC前体和经典的PDAC亚型中存在胃细胞特征.
- ROR2标志着一种类似胃代谢的身份,并对抗胃坑细胞身份.
- ROR2 除促进了胃腔细胞的识别,并改变了PDAC的进展.
- ROR2促进了表皮细胞转变为介质细胞,KRAS抑制剂耐药性和AKT抑制剂脆弱性.
结论:
- 在胰腺癌前病变和PDAC中,ROR2是细胞身份的关键调节者.
- ROR2驱动积极的PDAC表型,并赋予对KRAS抑制剂的耐药性.
- 向ROR2可能会提高对KRAS向疗法的敏感性.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K


